#Hemp Energy Drink Coming Soon to North America; Collaboration with
Tetra Bio-Pharma (TSXV: $TBP.V; OTCQB: $TBPMF) and Spyder Cannabis Inc. (TSXV:
$SPDR.V)
OTTAWA - June 19, 2019 (Investorideas.com Newswire)
Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX V: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder
Cannabis Inc. (TSX VENTURE: SPDR) ("Spyder") to distribute the three
flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores
in Canada and the US. The drink is expected to be available to consumers in
Spyder's retail stores located in Scarborough, Woodbridge, Burlington, and
shortly at the Niagara Falls and Pickering locations, which are expected to be
opened early this summer. A launch event will be held during the Canada Day
long weekend at the Niagara Falls location situated at 6474 Lundys Lane.
Read this in full at https://www.investorideas.com/news/2019/cannabis/06191HempEnergyDrink-NorthAmerica.asp
Tetra Bio-Pharma Hemp energy drinks
“We are very excited to be adding the Hemp Energy
Drink to our portfolio of premium brands that will be available to our growing
clientele,” stated Daniel Pelchovitz, CEO and President of Spyder. “This new
offering will please our customers who are always seeking unique and
distinctive quality products in this emerging industry.”
“This exclusive agreement allows us to take another
step in implementing our distribution strategy and achieving our goal of making
our Hemp Energy Drink accessible to all consumers “ said Richard Giguère, CEO
of Tetra Natural Health “Consumers appreciate the qualities of the Hemp Energy
Drink (HED) including the fact that it contains more natural ingredients than
other energy drinks, and is the first energy drink made with hemp available in
the country” adds Derek Theriault, National Sales Director of Tetra Natural
Health.
About Tetra Natural Health:
Tetra Natural Health Inc. is a subsidiary of Tetra
Bio-Pharma Inc. that focuses on identification, development and marketing of
hemp or cannabis-based natural health products, or cannabinoids-based products
authorized for sale by Health Canada. For more information, visit: www.tetranaturalhealth.com
About Spyder Cannabis Inc.
Founded in 2014 Spyder is an established chain of
three high-end vape stores in Ontario, with stores located in Woodbridge,
Scarborough and Burlington. The Spyder brand is defined by its high-quality
proprietary line of e-juice, liquids and exclusive retail deals, dispensed in
uniquely designed stores creating the optimal customer experience. Spyder is
building off this leading retail, distribution and branding eCig and vapes
company and is pursuing expansion into the legal cannabis market. Spyder has
developed a scalable retail model with an aggressive expansion plan to create a
significant retail footprint with targeted and disciplined retail distribution
strategy focusing on Canadian locations in high traffic peripheral areas.
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) a
biopharmaceutical leader in cannabinoid-based drug discovery and development
with a Health Canada approved and FDA reviewed clinical program aimed at bringing
novel prescription drugs and treatments to patients and their healthcare
providers. Tetra Bio-Pharma has subsidiaries engaged in the development of an
advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and
Veterinary Products containing cannabis and other medicinal plant-based
elements. With patients at the core of its mission, Tetra Bio-Pharma is focused
on providing rigorous scientific validation and safety data required for
inclusion into the existing bio pharma industry by regulators, physicians and
insurance companies. For more information visit: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain
forward-looking information. All statements, other than of historical fact,
that address activities, events or developments that the Company believes,
expects or anticipates will or may occur in the future (including, without
limitation, statements regarding potential acquisitions and financings) are
forward-looking statements. Forward-looking statements are generally
identifiable by use of the words "may", "will",
"should", "continue", "expect",
"anticipate", "estimate", "believe",
"intend", "plan" or "project" or the negative of
these words or other variations on these words or comparable terminology.
Forward-looking statements are subject to a number of risks and uncertainties,
many of which are beyond the Company's ability to control or predict, that may
cause the actual results of the Company to differ materially from those
discussed in the forward-looking statements. Factors that could cause actual
results or events to differ materially from current expectations include, among
other things, without limitation, the inability of the Company to obtain
sufficient financing to execute the Company's business plan; competition;
regulation and anticipated and unanticipated costs and delays, the success of
the Company's research and development strategies, the applicability of the
discoveries made therein, the successful and timely completion and
uncertainties related to the regulatory process, the timing of clinical trials,
the timing and outcomes of regulatory or intellectual property decisions and
other risks disclosed in the Company's public disclosure record on file with
the relevant securities regulatory authorities. Although the Company has
attempted to identify important factors that could cause actual results or events
to differ materially from those described in forward-looking statements, there
may be other factors that cause results or events not to be as anticipated,
estimated or intended. Readers should not place undue reliance on
forward-looking statements. While no definitive documentation has yet been
signed by the parties and there is no certainty that such documentation will be
signed The forward-looking statements included in this news release are made as
of the date of this news release and the Company does not undertake an
obligation to publicly update such forward-looking statements to reflect new
information, subsequent events or otherwise unless required by applicable
securities legislation.
For more information, please contact:
Tetra Natural Health
Richard Giguère, CEO
Tel.: (348) 899-7575 ext. 210
Spyder Cannabis Inc.
Dan Pelchovitz, President and CEO
Tel: (905) 265-8273
For TBP investors information, please contact:
(438) 504-5784
Media Contacts - Tetra Natural Health
Daniel Granger
ACJ Communication
W. 514 840-7990
M. 514 232-1556
Charlotte Blanche
W. 514 840-1235, ext. 7772
M. 514 914-0593
Investorideas.com publishing
disclaimer:
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. This Tetra Bio-Pharma release is a
paid for news release on Investorideas.com by( $750) learn more about our
2 day news service https://www.investorideas.com/News-Upload/.
More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Cannabis disclaimer
Investor
Ideas does not condone the use of cannabis except where permissible
Get
more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories
No comments:
Post a Comment